Articles from BroadOak Capital Partners
Quartzy, a vertically-integrated procurement platform for the life sciences industry, announced it has secured $23 million in financing from Avenue Capital Group and BroadOak Capital Partners.
By BroadOak Capital Partners · Via Business Wire · April 13, 2026
BroadOak Capital Partners (“BroadOak”), a life-sciences focused investment and advisory firm, today announced multiple growth investments across its platform, highlighted by the first investment from BroadOak Fund VI, a growth equity financing in Azure Biosystems. This marks the third time over two decades that BroadOak has successfully partnered with the founders of Azure.
By BroadOak Capital Partners · Via Business Wire · November 12, 2025
BroadOak Capital Partners ("BroadOak"), a life science focused investment and advisory firm, announced it has added over $200 million of permanent capital to its investing platform, a rare milestone that positions the firm to deploy patient, flexible capital across market cycles without the constraints of traditional fund structures and time horizons.
By BroadOak Capital Partners · Via Business Wire · October 28, 2025

BroadOak Capital Partners, long-known for its flexible growth capital and M&A advice focused within the life sciences tools, diagnostics and services sectors, today announced it has appointed Robert Wicke as an Operating Partner.
By BroadOak Capital Partners · Via Business Wire · November 16, 2021